Sunday, July 25, 2021
Home Search

Zydus Cadila - search results

If you're not happy with the results, please do another search
Medicine Tablet

Zydus Cadila gets USFDA nod for Ibrutinib tablets

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Ibrutinib tablets, in the strengths of...
USFDA

Zydus Cadila gets USFDA nod for drug to treat HIV infection

Zydus Cadila has received final approval from US Food and Drug Administration (USFDA) to market emtricitabine and tenofovir disoproxil fumarate tablets, 100...
Zudus

Zydus Cadila gets tentative nod from USFDA for Pemetrexed for Injection

Zydus Cadila has received tentative approval from the USFDA to market Pemetrexed for Injection in the strengths of 100mg/vial, 500 mg/vial, and...
USFDA

Zydus Cadila gets tentative nod from USFDA for Fingolimod Capsules

Zydus Cadila has received tentative approval from the United States US (USFDA) to market Fingolimod capsules in the strength of 0.25 mg...

Zydus Cadila gets tentative USFDA nod for Epilepsy drug

Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10 mg, 25 mg, 50...
Laboratory

Zydus Cadila gets nod for Clinical Trials of Antibodies cocktail

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of C-19 has been given...
USFDA

Zydus Cadila gets tentative USFDA nod for Osimertinib Tablets

Zydus Cadila has received tentative approval from the USFDA to market Osimertinib Tablets in the strengths of 40 mg and 80 mg...
Injection vaccine Medicine

Zydus Cadila plans to test its C-19 vaccine for 5-12 age group

After covering adults and children aged between 12 and 18 years under the ongoing clinical trials of its C-19 vaccine ZyKov-D, Zydus Cadila now plans to test its plasmid...
USFDA

Zydus Cadila gets USFDA nod for Fluphenazine HCL Tablets

Zydus Cadila has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg,...

Zydus Cadila launches drug for Breast cancer treatment

Zydus Cadila, a global innovation driven healthcare company, launched trastuzumab emtansine, the first antibody drug conjugate (ADC) biosimilar and a highly effective...
Zudus

Zydus Cadila’s Virafin priced at Rs 11,995 per dose

As per reports, Zydus Cadila has fixed the price of Virafin, a medicine that has received EUA for C-19 treatment, at Rs...
Zudus

Zydus Cadila gets final USFDA nod for drug to treat High BP

Zydus Cadila has received final approval from the USFDA to market Macitentan Tablets, 10 mg (US RLD: Opsumit Tablets).
Zudus

Zydus Cadila seeks DCGI nod for Hepatitis drug use in C-19 patient

Dr. VG Somani, DCGI New Delhi: Zydus Cadila has submitted its application to Dr V.G. Somani the Drugs...
Recall

Zydus Cadila, Alembic Pharma recall these 2 drugs in US

US-based units of Zydus Cadila and Alembic Pharmaceuticals are recalling one drug each in the US after receiving complaints against the products.
Medicine Capsule

Zydus Cadila gets USFDA nod for Anti Depressant drug

Zydus Cadila has received final approval from the USFDA to market Nortriptyline Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg and...
Medicine

Zydus Cadila gets USFDA nod for low Blood Pressure drug

Zydus Cadila on Friday said it has received final approval from the US health regulator to market Droxidopa capsules, used to treat low blood pressure.
Zydus Cadila gets USFDA nod for Thyroid drug

Zydus Cadila gets USFDA nod for Thyroid drug

New Delhi: Drug firm Zydus Cadila has received final approval from the US health regulator to market Liothyronine Sodium tablets that are used to treat underactive thyroid....
Medicine Tablets

Zydus Cadila gets tentative USFDA approval for Linagliptin Tablets

Zydus Cadila has received tentative approval from the USFDA to market Linagliptin Tablets, 5 mg (US RLD: Tradjenta Tablets).
Medicine

Zydus Cadila gets tentative USFDA approval for Dapagliflozin Tablets

Zydus Cadila has received tentative approval from the USFDA to market Dapagliflozin Tablets, 5 mg and 10 mg (US RLD: Farxiga Tablets)....
Medicine Tablets

Zydus Cadila gets USFDA nod to market Albuterol tablets

Zydus Cadila has received final approval from the US Food & Drug Administration (FDA) to market albuterol tablets in the strengths of...
Medicine Tablets

Zydus Cadila gets USFDA nod for bladder treatment drug

Drug firm Zydus Cadila on Tuesday said it has received final approval from the US health regulator to market Solifenacin Succinate tablets, used for treatment of...
Medicine

Zydus Cadila gets tentative USFDA nod for Tofacitinib ER tablets

Zydus Cadila has received tentative approval from the USFDA to market Tofacitinib Extended-Release Tablets, 11 mg (US RLD: Xeljanz XR Tablets).
Medicine

Zydus Cadila gets USFDA nod for Ursodiol capsules

New Delhi: Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Ursodiol capsules,...
Approved

Zydus Cadila gets USFDA Nod for Fingolimod cap, Verapamil HCL inj.

Zydus Cadila has received final approval from the USFDA to market Fingolimod Capsules, 0.5 mg (US RLD: Gilenya Capsules).

Latest posts

Report of Govt Analyst and CDL must give factual data (Part-1)

Report of Govt Analyst and CDL must give factual data The Drugs and Cosmetics Act, 1940, provides for...

Authors

42 POSTS0 COMMENTS
30 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS